Sage Journals: Discover world-class research

Free access

Announcement

First published 2012-7

Prevalence of Natural Polymorphisms at the HCV Ns5A Gene Associated with Resistance to Daclatasvir,An Ns5A Inhibitor

Zulema Plaza, Vincent Soriano, Eugenia Vispo [...]

Antiviral Therapy

Free access

Research article

First published 2018-4

Long-Term Persistence of HCV NS5A Resistance-Associated Substitutions after Treatment with the HCV NS5A Inhibitor,Ledipasvir,without Sofosbuvir

David Wyles, Alessandra Mangia, Wendy Cheng [...]

Antiviral Therapy

Free access

Announcement

First published 2015-1

Prevalence of Baseline Polymorphisms for Potential Resistance to NS5A Inhibitors in Drug-Naive Individuals Infected with Hepatitis C Genotypes 1–4

Adele L McCormick, Lawrence Wang, Ana Garcia-Diaz [...]

Antiviral Therapy

Free access

Announcement

First published 2016-7

Naturally Occurring HCV NS5A/B Inhibitor Resistance-Associated Mutations to Direct-Acting Antivirals

the Irish Hepatitis C Outcomes Research Network, Linh Thuy Nguyen, Naomi Hall [...]

Antiviral Therapy

Free access

Review article

First published 2017-1

Grazoprevir/elbasvir combination therapy for HCV infection

Anaïs Vallet-Pichard, Stanislas Pol

Therapeutic Advances in Gastroenterology

Free access

Research article

First published 2013-10

Assessment of Pharmacokinetic Interactions of the HCV Ns5A Replication Complex Inhibitor Daclatasvir with Antiretroviral Agents: Ritonavir-Boosted Atazanavir,Efavirenz and Tenofovir

Marc Bifano, Carey Hwang, Berend Oosterhuis [...]

Antiviral Therapy

Free access

Research article

First published 2016-4

Randomized Controlled Trial of the NS5A Inhibitor Daclatasvir plus Pegylated Interferon and Ribavirin for HCV Genotype-4 (COMMAND-4)

Christophe Hézode, Laurent Alric, Ashley Brown [...]

Antiviral Therapy

Retricted access

Review article

First published 2017-1

Sofosbuvir/Velpatasvir

Elias B. Chahine, Allana J. Sucher, Brian A. Hemstreet

Annals of Pharmacotherapy

Retricted access

Review article

First published 2016-1

Daclatasvir

Michael A. Smith, Randolph E. Regal, Rima A. Mohammad

Annals of Pharmacotherapy

Retricted access

Review article

First published 2018-4

Sofosbuvir/Velpatasvir/Voxilaprevir: A Pan-Genotypic Direct-Acting Antiviral Combination for Hepatitis C

Elias B. Chahine, Denise Kelley, Lindsey M. Childs-Kean

Annals of Pharmacotherapy

Search results